IMUNON INC (IMNN) Forecast, Price Target & Analyst Ratings
NASDAQ:IMNN • US15117N7012
3.24 USD
-0.1 (-2.99%)
Last: Mar 6, 2026, 08:26 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IMUNON INC (IMNN).
Forecast Snapshot
Consensus Price Target
$21.93
+ 576.85% Upside
Next Earnings Forecast
Release DateMar 26, 2026
PeriodQ4 / 2025
EPS Estimate-$1.20
Revenue Estimate
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$21.93
Upside
+ 576.85%
From current price of $3.24 to mean target of $21.93, Based on 10 analyst forecasts
Low
$12.12
Median
$20.91
High
$34.65
Price Target Revisions
1 Month
-66.35%
3 Months
-74.06%
Price Target Summary
10 analysts have analysed IMNN and the average price target is 21.93 USD. This implies a price increase of 576.85% is expected in the next year compared to the current price of 3.24.
The average price target has been revised downward by 74.06% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
IMNN was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IMNN.
In the previous month the buy percentage consensus was at a similar level.
IMNN was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-05-19 | D. Boral Capital | Downgrade | Buy -> Hold |
| 2025-05-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-07 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-24 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-27 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-19 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-24 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-19 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-10 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-07 | EF Hutton | Maintains | Buy -> Buy |
| 2024-10-31 | EF Hutton | Maintains | Buy -> Buy |
| 2024-09-23 | EF Hutton | Initiate | Buy |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 26, 2026
PeriodQ4 / 2025
EPS Estimate-$1.20
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q73.77%
Number of Analysts7
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
11.89%
EPS (3 Months)
11.73%
Next Earnings Summary
IMNN is expected to report earnings on 3/26/2026. The consensus EPS estimate for the next earnings is -1.2 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 500K | 500K | 500K | -100.00% | 19.142M | 67.449M 252.36% | 175.77M 160.60% | 675.14M 284.10% | 1.231B 82.33% | 1.873B 52.15% | |||||
| EBITDA YoY % growth | -17.75M 10.58% | -20.31M -14.42% | -24.19M -19.10% | N/A 14.09% | N/A 9.73% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -18.49M 10.11% | -21.01M -13.63% | -24.92M -18.61% | -19.686M 15.61% | -21.284M 9.65% | -19.763M -4.02% | -25.911M -31.11% | -31.324M -20.89% | -28.764M 8.17% | -3.506M 87.81% | 83.539M 2,482.69% | 561.26M 571.85% | 1.053B 87.61% | 1.621B 53.94% | |
| Operating Margin | -3,698.00% | -4,202.00% | -4,984.00% | N/A | N/A | N/A | N/A | N/A | -150.27% | -5.20% | 47.53% | 83.13% | 85.54% | 86.55% | |
| EPS YoY % growth | -131.09 9.46% | N/A 58.90% | -67.43 -25.15% | -27.54 57.83% | -22.52 21.10% | -5.08 77.34% | -3.43 32.54% | -3.08 10.16% | -2.83 8.16% | 1.84 164.86% | 9.89 438.89% | 65.03 557.22% | 111.38 71.29% | 164.63 47.80% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -1.20 73.77% | -1.06 70.95% | -0.63 66.45% | -0.61 47.68% |
| Revenue Q2Q % growth | N/A | N/A | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.035M -93.79% | -4.624M -11.54% | -3.535M -27.73% | -3.535M -1.71% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
23.07%
EPS Next 5 Year
15.79%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
IMUNON INC / IMNN Forecast FAQ
What do analysts expect the price target to be for IMUNON INC (IMNN)?
10 analysts have analysed IMNN and the average price target is 21.93 USD. This implies a price increase of 576.85% is expected in the next year compared to the current price of 3.24.
What is the next earnings date for IMNN stock?
IMUNON INC (IMNN) will report earnings on 2026-03-26, after the market close.
What are the consensus estimates for IMUNON INC (IMNN) next earnings?
The consensus EPS estimate for the next earnings of IMUNON INC (IMNN) is -1.2 USD and the consensus revenue estimate is 0 USD.
How many analysts have analysed IMUNON INC (IMNN)?
The number of analysts covering IMUNON INC (IMNN) is 10.